Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

After hours: March 7 at 7:59:01 PM EST Loading Chart for BILL ...

The biggest stories of the day delivered to your inbox.

BUSINESS NEWS - A tax-free savings account is still one of the best ways to save to reach your long-term financial... GEORGE NEWS - A 33-year-old man was taken into custody following the death of a ...

Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

News interviews in FULL! Highlighting some of the most interesting, intriguing and engaging recent Isle of Man stories from Manx Radio News.